Co-Located Conference AgendasADME and Toxicology 2013 | Nanomedicine |
Thursday, 30 May 201308:00 | Registration | 09:20 | Inauguration | 09:30 | | Keynote Presentation Regulations and Development in Safety Assessment of New Drugs in India Yogender Gupta, Professor, All India Institute of Medical Sciences, India
|
| 10:15 | Coffee Break and Networking in Exhibition Hall | 10:35 | | Keynote Presentation All About ADME: Why, When, Where and How Much? Jyoti Paliwal, Medical Advisor, Troikaa Pharmaceuticals Limited , India
|
| 11:15 | Challenges in ADME and Metabolomics Girish Jain, Scientist F, Central Drug Research Institute, India
| 11:45 | Roadmaps to Success in Novel Drug Discovery and Development through PADMET Profiling Pratima Srivastava, Associate Director, Gvk Biosciences Private Limited, India
| 12:15 | Recent Trends in Development on LCMS/MS Enabling Unique Workflow in Metabolite Identification Umesh Pawa, Managing Director, AB Sciex, United Arab Emirates
| 12:45 | Lunch in the Hall | 13:45 | Technology Spotlight: An Integrated Approach to Quick Lead Optimization Including Physiochemical and ADME Profiling K K Bhagchandani, Director, Advanced Chemistry Development Inc
| 14:00 | ADME, Dissolution and Bioavailability: Establishing a Relationship Manoj Karwa, Project Manager, Auriga Research Ltd, India
| 14:30 | | Keynote Presentation From Biostudies to Biowaivers using IVIVC Bhupinder Singh Bhoop, Dean, UIPS, Panjab University, India
|
| 15:10 | Coffee Break and Networking in Exhibition Hall | 15:30 | Preclinical Formulations for Early Discovery Invivo studies Deepak Barot, President & CEO, PBR Private Limited, India
| 16:30 | Atrovastatin Causing Peripheral Neuropathy - Is It a Signal? Harmeet Rehan, Professor & Head, Lady Hardinge Medical College, India
| 17:00 | End of the Day | 18:00 | Drink Reception and Networking |
Friday, 31 May 201309:00 | | Keynote Presentation Multi-parameter Optimization in Drug Discovery: Quickly Targeting Compounds with a Good Balance of Properties Matthew Segall, Chief Executive Officer, Optibrium Ltd, United Kingdom
|
| 09:40 | Integrating In Vitro and In Silico Approaches for Mechanistic Toxicology Sonali Das, Director, Strand Life Sciences Pvt Ltd, India
| 10:10 | Coffee Break and Networking in Exhibition Hall | 10:30 | Therapeutic Drug Monitoring and Drug Safety Kamal Kishore, Professor, All India Institute of Medical Sciences, India
| 11:00 | Newer Strategies in Drug Safety Research: A Translational Approach Kavita Gulati, Associate Professor in Pharmacology, Vallabhbhai Patel Chest Institute, India
| 11:30 | Recent Amendments to the Indian Clinical Trial Regulations and its Impact on the Clinical Research Industry Bobby George, Vice President & Head Regulatory Affairs, Reliance Life Sciences Pvt Ltd, India
| 12:00 | Bioavailability and Bioequivalence Pharmacokinetic Studies: An FDA Regulatory Overview Shiva Nanjundappa, Head, Jubliant Clinsys Ltd, India
| 12:30 | Issues and Challenges in Clinical Pharmacokinetic Evaluation of a New Drug Molecule Samir Malhotra, Professor, PGIMER, India
| 13:00 | Poster Session | 13:20 | Lunch in the Hall | 14:20 | Personalized Medicine: The Leading Edge in Human Health Ritushree Kukreti, Scientist, Institute of Genomics and Integrative Biology, India
| 14:50 | Genotoxicity Testing in Drug Safety Evaluation: Models, Bioassays and End-points for Regulatory Consideration G Jena, Assistant Professor, National Institute of Pharmaceutical Education and Research, India
| 15:20 | Coffee Break and Networking in Exhibition Hall | 15:40 | Preclinical Evaluation of Drug Safety Arunabha Ray, Professor/Head, University of Delhi, India
| 16:10 | Bioinformatics Concept, Methods & Techniques for ADME, Toxicology & Drug Designing Vivek Keshri, Research Associate, National Bureau of Agriculturally Important Microorganisms, India
| 16:30 | Panel Discussion: Pre-clinical and Clinical Outsourcing- Current Indian Scenario | 17:00 | End of the Conference |
|